Press Releases

Upcoming Events

UBS Global Healthcare Conference 2019
Monday, May 20 - Wednesday, May 22

New York, NY

BIO International Convention 2019
Monday, June 03 - Thursday, June 06

Philadelphia, PA

> See all Events
September 21, 2011

VenatoRx has been awarded a Phase 1 SBIR Grant for novel approaches to address multi-drug resistant gram-negative infections. The company may receive up to $600,000 of funding under the grant.

August 21, 2011

VenatoRx has been awarded a Phase 1 SBIR Grant for novel approaches to address multi-drug resistant gram-negative infections. The company may receive up to $600,000 of funding under the grant.

Archive: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010